Otosclerosis: audiometric results and quality of life after stapedectomy with interposition or CO


Journal

Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354

Informations de publication

Date de publication:
Mar 2023
Historique:
medline: 28 3 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

The surgical treatment of otosclerosis consists of the replacement of the stapes using a piston. The objective of this study is to assess the audiometric results and quality of life (QOL) of patients who underwent surgery for otosclerosis by stapedectomy with fascia interposition (STIP) or by stapedotomy using CO Ninety-one patients operated on for otosclerosis by STIP (40 patients) and by SLaser (51 patients) were included. Audiometric results were graphically displayed using the Amsterdam Hearing Evaluation Plot and were compared to the Common Otology Database (COD) comprising 660 patients. The patients' QOL was assessed with an otological validated survey. The significance level was There was no significant difference in hearing improvement between SLaser and STIP-operated patients. There was no significant difference between our results and that of COD. QOL was significantly improved (+3.5/10) postoperatively for both STIP and SLaser in both social and professional fields. By comparing QOL and hearing gain of STIP and SLaser, our results suggest that both surgical techniques are a safe and successful treatment for otosclerotic stapes fixation. Further studies aiming at comparing larger series may confirm and refine these results.

Sections du résumé

BACKGROUND UNASSIGNED
The surgical treatment of otosclerosis consists of the replacement of the stapes using a piston.
AIMS/OBJECTIVES UNASSIGNED
The objective of this study is to assess the audiometric results and quality of life (QOL) of patients who underwent surgery for otosclerosis by stapedectomy with fascia interposition (STIP) or by stapedotomy using CO
MATERIAL AND METHODS UNASSIGNED
Ninety-one patients operated on for otosclerosis by STIP (40 patients) and by SLaser (51 patients) were included. Audiometric results were graphically displayed using the Amsterdam Hearing Evaluation Plot and were compared to the Common Otology Database (COD) comprising 660 patients. The patients' QOL was assessed with an otological validated survey. The significance level was
RESULTS UNASSIGNED
There was no significant difference in hearing improvement between SLaser and STIP-operated patients. There was no significant difference between our results and that of COD. QOL was significantly improved (+3.5/10) postoperatively for both STIP and SLaser in both social and professional fields.
CONCLUSIONS AND SIGNIFICANCE UNASSIGNED
By comparing QOL and hearing gain of STIP and SLaser, our results suggest that both surgical techniques are a safe and successful treatment for otosclerotic stapes fixation. Further studies aiming at comparing larger series may confirm and refine these results.

Identifiants

pubmed: 36939022
doi: 10.1080/00016489.2023.2186482
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-236

Auteurs

Ramzi R Maalouf (RR)

Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.

Morgane Marc (M)

Department ENT - Sydney Adventist Hospital, University of Sydney, Australia.

Vincent Van Rompaey (V)

Department of ENT and Head and Neck Surgery, Antwerp University Hospital Center, Edegem, Belgium.

Michael Eliezer (M)

Department of Radiology, Lariboisière Hospital, Paris, France.

Charlotte Hautefort (C)

Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.

Benjamin Verillaud (B)

Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.

Philippe Herman (P)

Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.

Romain Kania (R)

Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH